Abstract P5-21-02: Hormone receptor status and endocrine therapy in a prospective observation study on trastuzumab (Herceptin®) in the adjuvant treatment of breast cancer

2012 ◽  
Author(s):  
P Dall ◽  
K Friedrichs ◽  
V Petersen ◽  
A Hinke ◽  
C Brucker ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Endocrine Therapy ◽  
Adjuvant Treatment ◽  
Hormone Receptor ◽  
Hormone Receptor Status ◽  
Observation Study ◽  
Receptor Status

Lack of Knowledge of Hormone Receptor Status and Use of Endocrine Therapy in Invasive Breast Cancer

2009 ◽  
Vol 18 (12) ◽  
pp. 1975-1980 ◽  
Author(s):  
Robin J. Bell ◽  
Marijana Lijovic ◽  
Pam Fradkin ◽  
Jo Bradbury ◽  
Maria La China ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Endocrine Therapy ◽  
Invasive Breast Cancer ◽  
Hormone Receptor ◽  
Hormone Receptor Status ◽  
Receptor Status ◽  
Lack Of Knowledge

Immunohistochemical evaluation of hormone receptor status for predicting response to endocrine therapy in metastatic breast cancer

Breast Cancer ◽  
2006 ◽  
Vol 13 (1) ◽  
pp. 74-83 ◽  
Author(s):  
Hiroko Yamashita ◽  
Yoshiaki Ando ◽  
Mariko Nishio ◽  
Zhenhuan Zhang ◽  
Maho Hamaguchi ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Metastatic Breast Cancer ◽  
Endocrine Therapy ◽  
Hormone Receptor ◽  
Metastatic Breast ◽  
Hormone Receptor Status ◽  
Receptor Status

Hormone receptor status in primary breast cancer—time for a consensus?

2002 ◽  
Vol 38 (9) ◽  
pp. 1201-1203 ◽  
Author(s):  
G.C Wishart ◽  
M Gaston ◽  
A.A Poultsidis ◽  
A.D Purushotham
Keyword(s):  
Breast Cancer ◽  
Hormone Receptor ◽  
Primary Breast Cancer ◽  
Hormone Receptor Status ◽  
Receptor Status

A STUDY ON HORMONE RECEPTOR STATUS IN BREAST CANCER IN RELATION TO HISTOLOGICAL GRADING, AGE AND LYMPH NODE INVOLVEMENT

2021 ◽  
pp. 41-44
Author(s):  
R. Rani Suganya ◽  
M. Annapoorani ◽  
C. Naveen Kumar
Keyword(s):  
Breast Cancer ◽  
Lymph Node ◽  
Hormone Receptor ◽  
Histological Grade ◽  
Systemic Disease ◽  
Lymph Node Involvement ◽  
Hormone Receptor Status ◽  
Major Health Problem ◽  
Receptor Status ◽  
Node Involvement

Breast cancer is the major health problem for the women throughout the world.Management of breast cancer has evolved to include both surgery for local disease and medical therapy for systemic disease. Multiple treatment options are available depending on various factors such as histological grade, hormone receptor status etc. The aim of this study is to correlate the hormone receptor status with prognostic factors such as lymph node involvement, tumour grading and age among patients diagnosed with breast cancer in our institution. The results of this study serve to prognosticate the severity of disease among various strata of patients.

scholarly journals Is the biology of breast cancer changing? A study of hormone receptor status 1984–86 and 1996–1997

2008 ◽  
Vol 34 (10) ◽  
pp. 1172
Author(s):  
Sylvia Brown ◽  
E. Mallon ◽  
J. Edwards ◽  
F. Campbell ◽  
L. McGlynn ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Hormone Receptor ◽  
Hormone Receptor Status ◽  
Receptor Status

scholarly journals Effect of intraoperative radiotherapy on wound healing in breast cancer patient post breast conserving surgery, KSUMC, Riyadh, Saudi Arabia: Case series and review of literature.

2019 ◽  
Vol 6 (06) ◽  
pp. 4505-4510
Author(s):  
Dr. Maha Alamodi Alghamdi ◽  
Abdulaziz Saleh Altwjri ◽  
Abdullah Alsuhaibani ◽  
Abdulaziz Alsaif
Keyword(s):  
Breast Cancer ◽  
Hormone Receptor ◽  
External Beam Radiotherapy ◽  
Intraoperative Radiotherapy ◽  
Breast Conserving Surgery ◽  
Hormone Receptor Status ◽  
Wound Complications ◽  
External Beam ◽  
X Rays ◽  
Receptor Status

Intraoperative radiotherapy during breast-conserving surgery is being studied as an alternative to 6 weeks of external beam radiotherapy (EBRT) for low-risk women; it can be delivered using electrons (intraoperative electron radiotherapy, IOERT) or 50-kV X-rays. Intraoperative radiation therapy (IORT) may pose a risk for wound complications.  Between March 2018 and June 2018, 5 breast cancer patients, all eligible for breast conserving surgery (BCS), were treated at the King Saud Medical city with IORT using the IOERT. Complete data sets for age, stage (T, N, and M), and histology and hormone receptor status were available in 5 cases. Parameters to identify eligible patients are as follows: ESTRO: >50 years, invasive ductal carcinoma/other favourable histology (IDC), T1-2 (≤3 cm), N0, any hormone receptor status, M0; ASTRO: ≥60 years, IDC, T1, N0, positive estrogen hormone receptor status, M0; TARGIT E “elderly”, risk adapted radiotherapy with IORT followed by external beam radiotherapy in case of risk factors in final histopathology. Consecutive patients operated on with the same surgical technique and given IORT were included. Wound complications were evaluated.

scholarly journals Physical activity and risk of breast cancer overall and by hormone receptor status: The European prospective investigation into cancer and nutrition

2012 ◽  
Vol 132 (7) ◽  
pp. 1667-1678 ◽  
Author(s):  
Karen Steindorf ◽  
Rebecca Ritte ◽  
Piia-Piret Eomois ◽  
Annekatrin Lukanova ◽  
Anne Tjonneland ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Physical Activity ◽  
Hormone Receptor ◽  
Hormone Receptor Status ◽  
Receptor Status ◽  
Prospective Investigation
Sign in / Sign up

Export Citation Format

Share Document